Business · 20/01/2023
FDA Announces Draft Guidance for Developing Mpox Drugs and Biological Products
The US Food and Drug Administration (FDA) has released a draft guidance to help pharmaceutical companies develop drugs and biological products to combat mpox, a viral disease.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →